\-\ Texto\\:\\ \ \(0\)\
\-\ on\\ exam\\,\\ the\\ patient\\ had\\ ttp\\ very\\ well\\ localized\\ to\\ the\\ llq\\ with\\ borderline\\ peritoneal\\ signs\\.\\ \\ the\\ patient\\ was\\ afebrile\\ with\\ only\\ a\\ mildly\\ elevated\\ wbc\\ count\\.\ \(0\)\
\-\ on\\ imaging\\,\\ there\\ is\\ an\\ ovoid\\,\\ fat\\ density\\ structure\\ \\(slightly\\ greater\\ than\\ normal\\ fat\\ attenuation\\)\\,\\ adjacent\\ to\\ the\\ sigmoid\\ colon\\.\\ \\ there\\ is\\ a\\ hyperdense\\ rim\\ with\\ some\\ surrounding\\ fat\\ stranding\\.\\ \\ there\\ is\\ a\\ central\\ focus\\ of\\ increased\\ density\\.\ \(0\)\
\-\ epiploic\\ appendagitis\ \(11\)\
\-\ these\\ findings\\ are\\ characteristic\\ of\\ primary\\ epiploic\\ appendagitis\\.\ \(0\)\
\-\ 42\\ yo\\ white\\ male\\ with\\ acute\\ onset\\ llq\\ pain\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ appendagitis\\:\\ 0\\.1233464964929955\ \(0\)\
\-\ llq\\:\\ 0\\.12105318442886717\ \(0\)\
\-\ epiploic\\:\\ 0\\.11803043238367386\ \(0\)\
\-\ fat\\:\\ 0\\.08037873163551444\ \(0\)\
\-\ borderline\\:\\ 0\\.058118191686789195\ \(0\)\
\-\ density\\:\\ 0\\.057971780553813586\ \(0\)\
\-\ ttp\\:\\ 0\\.04995078876715852\ \(0\)\
\-\ ovoid\\:\\ 0\\.048501490307146254\ \(0\)\
\-\ peritoneal\\:\\ 0\\.04583577908762347\ \(0\)\
\-\ sigmoid\\:\\ 0\\.04484134335373108\ \(0\)\
\-\ 42\\:\\ 0\\.04460703148695215\ \(0\)\
\-\ hyperdense\\:\\ 0\\.044043542697902005\ \(0\)\
\-\ localized\\:\\ 0\\.0429026605547317\ \(0\)\
\-\ stranding\\:\\ 0\\.0426122391427039\ \(0\)\
\-\ afebrile\\:\\ 0\\.0407008657062981\ \(0\)\
\-\ structure\\:\\ 0\\.04001076794676089\ \(0\)\
\-\ focus\\:\\ 0\\.03957509980975179\ \(0\)\
\-\ there\\:\\ 0\\.039331408962834706\ \(0\)\
\-\ count\\:\\ 0\\.038305690681879376\ \(0\)\
\-\ mildly\\:\\ 0\\.03751926485971824\ \(0\)\
\-\ rim\\:\\ 0\\.037288880337120335\ \(0\)\
\-\ characteristic\\:\\ 0\\.037288880337120335\ \(0\)\
\-\ slightly\\:\\ 0\\.03561057998203168\ \(0\)\
\-\ attenuation\\:\\ 0\\.035418773921917925\ \(0\)\
\-\ colon\\:\\ 0\\.03459724649301381\ \(0\)\
\-\ greater\\:\\ 0\\.033089859357427844\ \(0\)\
\-\ wbc\\:\\ 0\\.03211417371727641\ \(0\)\
\-\ very\\:\\ 0\\.0319771713243003\ \(0\)\
\-\ signs\\:\\ 0\\.031003875608103654\ \(0\)\
\-\ elevated\\:\\ 0\\.029889859395454257\ \(0\)\
\-\ white\\:\\ 0\\.02921756920321668\ \(0\)\
\-\ central\\:\\ 0\\.028985890276906793\ \(0\)\
\-\ surrounding\\:\\ 0\\.028960466642935726\ \(0\)\
\-\ adjacent\\:\\ 0\\.027853981898291413\ \(0\)\
\-\ onset\\:\\ 0\\.02780846624665103\ \(0\)\
\-\ some\\:\\ 0\\.026751837668729475\ \(0\)\
\-\ yo\\:\\ 0\\.026508778590750123\ \(0\)\
\-\ only\\:\\ 0\\.02648877998438078\ \(0\)\
\-\ primary\\:\\ 0\\.02609674497830615\ \(0\)\
\-\ than\\:\\ 0\\.0230829778857554\ \(0\)\
\-\ these\\:\\ 0\\.022926233937709692\ \(0\)\
\-\ acute\\:\\ 0\\.02175133328975768\ \(0\)\
\-\ increased\\:\\ 0\\.021551389503089234\ \(0\)\
\-\ imaging\\:\\ 0\\.02063993633459384\ \(0\)\
\-\ well\\:\\ 0\\.019928669618233516\ \(0\)\
\-\ exam\\:\\ 0\\.01935292721597462\ \(0\)\
\-\ had\\:\\ 0\\.019008761023100083\ \(0\)\
\-\ findings\\:\\ 0\\.018750896245257314\ \(0\)\
\-\ patient\\:\\ 0\\.01766168929724511\ \(0\)\
\-\ is\\:\\ 0\\.017390436444888423\ \(0\)\
\-\ male\\:\\ 0\\.015929953998839928\ \(0\)\
\-\ on\\:\\ 0\\.014925587883823258\ \(0\)\
\-\ normal\\:\\ 0\\.013810437676279392\ \(0\)\
\-\ a\\:\\ 0\\.01226597325212169\ \(0\)\
\-\ an\\:\\ 0\\.012182112002935359\ \(0\)\
\-\ are\\:\\ 0\\.012009008995150533\ \(0\)\
\-\ \\,\\:\\ 0\\.011163301670815974\ \(0\)\
\-\ pain\\:\\ 0\\.010758847087945719\ \(0\)\
\-\ was\\:\\ 0\\.010188428064058628\ \(0\)\
\-\ to\\:\\ 0\\.008805528009133737\ \(0\)\
\-\ \\(\\:\\ 0\\.007447028105606809\ \(0\)\
\-\ \\)\\:\\ 0\\.007356058681580464\ \(0\)\
\-\ the\\:\\ 0\\.0057010014310773524\ \(0\)\
\-\ with\\:\\ 0\\.004824914477933598\ \(0\)\
\-\ \\.\\:\\ 0\\.002561822192591999\ \(0\)\
\-\ of\\:\\ 0\\.0024021402226389365\ \(0\)\
